Skip to content

Author

F. Kawakami

We have 4 of 86 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Point-of-Care Assessment of Kidney Function in Chronic Kidney Disease: Current Technologies and Future Perspectives

Chronic kidney disease (CKD) requires assessment of both glomerular filtration and kidney damage, particularly albuminuria, for diagnosis, risk stratification, and longitudinal care. Point-of-care testing (POCT) can shorten turnaround time and improve access when conventional laboratory testing is unavailable or would...

Atthaphong Phongphithakchai, Kraiyasak Wongna, Ratana Netphakdee et al. · 0 citations
Open access Aug 2026

Eosinophil-associated intestinal immune responses following SARS-CoV-2 infection in K18-hACE2 mice

Background Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is frequently associated with gastrointestinal manifestations; however, intestinal immune responses following SARS-CoV-2 infection remain incompletely understood. This study aimed to characterize eosi...

Shun Tamaki, Rei Kawashima, Takayuki Uematsu et al. · 0 citations
Review Open access Jul 2026

Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities

Overall, current evidence suggests that AM has preliminary renoprotective potential in experimental AKI models, however, the limited number of available studies, predominance of cisplatin-induced nephrotoxicity models, insufficient pharmacokinetic and safety data, and absence of human clinical studies preclude conclusi...

Atthaphong Phongphithakchai, Nawanwat C. Pattaranggoon, Kraiyasak Wongna et al. · 0 citations
Review Open access Sep 2026

HSP47 in Mitochondria: Roles in Apoptosis, Signal Transduction, and Protein and Virus Transportation

Overall, these findings establish HSP47 as a novel regulator of mtROS generation, suggesting that the HSP47–mtROS axis represents a promising therapeutic target for oxidative stress-related disorders and a potential role for exploring virus-induced cellular responses in future research.

S. Surinkaew, N. Hosoya, Hiromu Ito et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.